Retraction Watch

Former Harvard cancer researcher plagiarized data, federal watchdog says

A former research fellow at Harvard Medical School faked data and used images from another scientist without attribution in a published paper and two grant applications, according to findings from the U.S. Office of Research Integrity.

The researcher, Arunoday K. Bhan, was also a former staff scientist at City of Hope Medical Center in Duarte, Calif., and first author on “Human induced pluripotent stem cell-derived platelets loaded with lapatinib effectively target HER2+ breast cancer metastasis to the brain,” which appeared in Scientific Reports in October 2021. The article has been cited eight times.

The paper was retracted in March. The retraction note cited an investigation by City of Hope and detailed “discrepancies in the data” that match ORI’s findings.

Pakistan university’s pharmacy department chair notches two retractions

Kashif Barkat, who heads the Department of Pharmacy at the University of Lahore in Punjab, Pakistan, has had two of his studies retracted and two more corrected, all for issues related to images in the papers. Several more of his studies are flagged on PubPeer for similar reasons.

According to the retraction notice for one of the retracted articles, which appeared in Polymer Bulletin in 2020, Barkat does not agree with the journal’s decision to pull the paper.

The paper, “Understanding mechanical characteristics of pH-responsive PEG 4000-based polymeric network for colorectal carcinoma: its acute oral toxicity study,” has been cited three times so far, according to Clarivate’s Web of Science.

The retraction note, issued in June, reads:

Weekend reads: A plethora of misdeeds; big slowdown at several publishers; hydroxychloroquine paper retraction draws scrutiny

The week at Retraction Watch featured:

Our list of retracted or withdrawn COVID-19 papers is up past 400. There are more than 50,000 retractions in The Retraction Watch Database — which is now part of Crossref. The Retraction Watch Hijacked Journal Checker now contains more than 250 titles. And have you seen our leaderboard of authors with the most retractions lately — or our list of top 10 most highly cited retracted papers? What about The Retraction Watch Mass Resignations List — or our list of nearly 100 papers with evidence they were written by ChatGPT?

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

Swiss medical association accused of forcing publishing subsidiary into insolvency

A Swiss medical publisher has ceased operations, including shuttering nationally prominent journals, after its parent organization, the Swiss Medical Association FMH, allegedly forced it into bankruptcy.

According to information on the website of EMH Swiss Medical Publishers, the Swiss Medical Association FMH holds a 55% stake in the firm. But on Aug. 22, 2024, the FMH’s board terminated its collaboration with the publishing house, including licensing for the association’s journal Schweizerische Ärztezeitung (Swiss Medical Journal), with immediate effect.

“In doing so, [the association] deprived its own company of its livelihood. EMH filed its balance sheet today and thus opened bankruptcy proceedings,” the publisher said in a notice posted on its website on September 4, 2024.

‘The PubPeer conundrum:’ One view of how universities can grapple with a ‘waterfall of data integrity concerns’

As Retraction Watch readers no doubt know, PubPeer has played a key role in a growing number of cases of misconduct, allowing sleuths to publicly shine light in shadowy corners and prompting action by many universities. (Disclosure: Our Ivan Oransky is a volunteer member of the PubPeer Foundation’s board of directors.) But that has also meant that universities can feel overwhelmed by a deluge of PubPeer comments.

In a new article, three attorneys from Ropes & Gray in Boston who advise universities on such cases, along with Barbara Bierer, a researcher and former research integrity officer at the Brigham and Women’s Hospital, also in Boston, examine “the origins of PubPeer and its central role in the modern era of online-based scouring of scientific publications for potential problems and outlines the challenges that institutions must manage in addressing issues identified on PubPeer.” Attorneys Mark Barnes, Minal Caron and Carolyn Lye, and the Brigham’s Barbara Bierer, also recommend ways federal regulations could change to make the investigation process more efficient. We asked them to answer some questions about the article.

What prompted you to write this piece?

Faked data prompts retraction of Nature journal study claiming creation of a new form of carbon

The journal Nature Synthesis has pulled a high-profile article describing the creation of a new type of carbon after a university investigation found some data were made up.

“The authors of the original paper claimed to have created an entirely new form or carbon, graphyne, which is fundamentally different common diamond or graphite,” said Valentin Rodionov, an assistant professor at Case Western Reserve University in Cleveland, Ohio, whose team has been investigating the now-retracted work for the past two years.

“If true, this would have been a groundbreaking discovery,” Rodionov told Retraction Watch. His team described its findings in a commentary published on September 2 in the journal.

Exclusive: Editor resigns after he says publisher blocked criticism of decision to retract paper on gender dysphoria

A Springer Nature journal has rescinded the acceptance of a paper criticizing the publishing giant’s controversial retraction last year of an article that surveyed parents of children with gender dysphoria, leading an associate editor to resign, Retraction Watch has learned.

According to emails we obtained, the blocked paper was slated to appear as a commentary in a special issue of Springer Nature’s Current Psychology that aimed “to stimulate discussion of all aspects of the ‘unpublication’ of scientific articles.”

“This is the only time I’ve had an accepted paper overruled in 4 years” as an associate editor at this journal, Christopher Ferguson of Stetson University in Florida, one of two guest editors of the special issue, told us by email.

Journal to retract two articles more than six months after VA said they had fake images

The Journal of Cellular Physiology, a Wiley title, will retract two articles by an arthritis researcher the U.S. Department of Veterans Affairs found to have engaged in research misconduct, Retraction Watch has learned.

Last November, the VA published findings stating Hee-Jeong Im Sampen, formerly a research biologist at the Jesse Brown Veterans Affairs Medical Center in Chicago, faked images and inflated sample sizes in three published papers, a grant application, a presentation, and an unpublished manuscript.

Based on the findings, the VA banned Sampen, who publishes under the name Hee-Jeong Im, from conducting research for the department and requested retractions of the three publications.

Two of the papers, “Development of an Experimental Animal Model for Lower Back Pain by Percutaneous Injury-Induced Lumbar Facet Joint Osteoarthritis” and “Environmental Disruption of Circadian Rhythm Predisposes Mice to Osteoarthritis-Like Changes in Knee Joint,” appeared in the Journal of Cellular Physiology in 2015, and don’t currently have any sort of notice about the VA finding they contain faked images.

Weekend reads: When retracted work is cited; another retraction for a Nobelist; should scientific fraud be illegal?

Would you consider a donation to support Weekend Reads, and our daily work?

The week at Retraction Watch featured:

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

Researcher whose work was plagiarized haunted by impostor emails

A researcher who posted on LinkedIn about a paper that plagiarized his work says he’s now the subject of an email campaign making false allegations about his articles.

In July, we reported that Sasan Sadrizadeh, researcher at KTH Royal Institute of Technology in Stockholm, had his work plagiarized in a now-retracted paper.

“In what seems to be a direct response to our efforts,” as Sadrizadeh wrote in a recent LinkedIn post, his bosses, colleagues, and journals have been inundated with emails from impostors, accusing Sadrizadeh of misuse of funds and calling for the removal of his articles. At least one journal editor seems to have taken the allegations seriously.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: